Black Rose Industries LtdQ1 FY23Chemicals & Petrochemicals

Black Rose Industries Ltd

Q1 FY23 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 1

Fundraise

N/A

Order

N/A

Capex

Yes

2 of 3 growth signals are positive.

Revenue guidance

Category 3

→The company anticipates revenue growth of 10-30% in the current year but will provide updates on a quarter-to-quarter basis as visibility improves.
→Q4 FY23 saw improving margins and the company expects this trend to continue with better results and opportunities ahead.
→Export volumes are being focused on due to higher realizations compared to the domestic market.
→Manufacturing revenues are expected to pick up in coming quarters, moving towards parity with distribution revenues.
→A fourfold increase in sales of N-methylol acrylamide is expected next quarter following customer approvals.
→Ongoing R&D and feasibility studies with Japanese, US, and European partners may add future revenue streams.
→Volume-wise, FY23 volumes for acrylamide were slightly lower than FY22, but Q4 volumes increased significantly.
→Overall, the mood within the organization is positive with expectations of stabilization, market improvements, and profitability growth.

Category 1

→The company expects revenue growth of 10-30% in the year but will provide updates quarter-to-quarter rather than giving full-year guidance due to high uncertainty.
→EBITDA margins are currently in double digits and are expected to improve further with better procurement and inventory management.
→Margin improvements have already begun, especially on acrylamide products, with doubling of margins seen in the last quarter.
→The company is cautiously maintaining low inventory levels to benefit from raw material price falls and better margin stability.
→Earnings growth outlook is positive but incremental and gradual, with better profitability expected as market conditions stabilize and costs reduce.
→EPS for FY23 was 1.29, and with improved margins and volumes, future EPS is expected to improve correspondingly.
→Management prefers to update on earnings outlook quarter-wise to avoid misleading information due to market volatility.

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Black Rose Industries Ltd and 1,400+ other companies.

→No specific information or announcements were made regarding current or future fundraising through debt or equity in the transcript.
→The company is in a strong financial position with zero long-term debt and a very low debt-equity ratio of 0.02.
→Cash flow from operations is strong at 225 million, supporting operational needs.
→Any future developments, including potential fundraising activities, are under secrecy agreements or not disclosed.
→Management prefers to share information proactively when appropriate and feasible, especially in physical meetings like AGMs.
→No explicit plans for debt or equity fundraising were indicated during this webinar.

→The transcript does not explicitly mention details about the current or expected order book or pending orders.
→There is no direct disclosure regarding the size, value, or status of order books.
→Discussions focus more on financial performance, R&D projects (like PAM Solid), capacity, and market outlook.
→Confidentiality and secrecy agreements restrict sharing certain operational details, such as toll manufacturing plant specifics.
→Management emphasizes cautious optimism with improving margins and stabilization in markets but refrains from giving specific future orders or order book guidance.
→Future developments and significant updates will be shared in subsequent webinars or physical meetings when available.

Yes

→Ongoing and upcoming projects include R&D on ceramic binders, acrylic dispersants (polycarboxylates and polyacrylamide solids).
→Feasibility study underway for a specialty chemical project in collaboration with a Japanese company.
→Discussions ongoing for two potential toll manufacturing projects with US and European companies; details under secrecy agreements.
→Manufacturing business CapEx remains largely unchanged at approximately ₹58 crores.
→Expansion potential exists: current acrylamide liquid capacity is 32,000 tons, with room to expand by another 60,000 tons.
→PAM Solid project is under R&D for about a year with construction pending post-completion; technology being developed in-house.
→Expected CapEx and construction timelines not disclosed due to confidentiality.

How does Black Rose Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Black Rose Industries Ltd

Rev 3Mar 1

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Black Rose Industries Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.